Important Disclosures Executive Statement and Audit Notes The Board, Supervisory Board, and senior management guarantee the truthfulness, accuracy, and completeness of this quarterly report, noting the financial statements are unaudited - The company's directors, supervisors, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false records, misleading statements, or major omissions2 - The company's principal, chief accountant, and head of accounting department guarantee the truthfulness, accuracy, and completeness of the financial statement information in the quarterly report3 - The financial statements for the first quarter of 2022 are unaudited4 Key Financial Data Core Financial Indicators In Q1 2022, revenue grew 14.09% to CNY 917.01 million, with net profit attributable to shareholders increasing 17.69% to CNY 93.44 million Key Financial Data for Q1 2022 | Indicator | Current Period | YoY Change (%) | | :--- | :--- | :--- | | Operating Revenue (CNY) | 917,007,642.00 | 14.09 | | Net Profit Attributable to Listed Company Shareholders (CNY) | 93,435,319.02 | 17.69 | | Net Cash Flow from Operating Activities (CNY) | -296,019,165.49 | Not Applicable | | Basic Earnings Per Share (CNY/share) | 0.14 | 16.67 | | Weighted Average Return on Net Assets (%) | 2.37 | Increased 0.03 percentage points | | Balance Sheet Items | As of Current Period End | Change from Prior Year-End (%) | | Total Assets (CNY) | 10,065,523,377.07 | -5.85 | | Total Equity Attributable to Listed Company Shareholders (CNY) | 3,981,083,171.29 | 2.65 | Non-Recurring Gains and Losses Non-recurring gains and losses totaled CNY 3.67 million for the period, primarily driven by CNY 4.38 million in government subsidies Details of Non-Recurring Gains and Losses for Q1 2022 | Item | Amount (CNY) | | :--- | :--- | | Gains/Losses from Disposal of Non-Current Assets | 52,266.78 | | Government Subsidies Included in Current Profit/Loss | 4,381,081.74 | | Other Non-Operating Income and Expenses | 58,997.67 | | Less: Income Tax Impact | 686,703.95 | | Less: Impact on Minority Interests (After Tax) | 136,356.38 | | Total | 3,669,285.86 | Analysis of Key Financial Indicator Changes R&D expenses increased 36.48% due to new innovation institute investments, while accounts receivable notes rose 115.41% from increased bill collections Changes in Key Financial Indicators and Reasons | Item Name | Change (%) | Primary Reason | | :--- | :--- | :--- | | Research and Development Expenses | 36.48 | Primarily due to increased R&D investment from the group's newly established innovation institute | | Notes Receivable | 115.41 | Primarily due to increased collection of acceptance bills in Q1 | | Short-term Borrowings | -32.01 | Primarily due to repayment of bank loans | | Notes Payable | 67.14 | Primarily due to an increase in acceptance bills issued | Shareholder Information Shareholding Structure As of the reporting period end, the company had 19,864 common shareholders, with the top ten holding a dispersed stake, led by Yang Weidong at 3.98% - As of the end of the reporting period, the company had a total of 19,864 common shareholders10 Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Type | Shareholding (%) | | :--- | :--- | :--- | | Yang Weidong | Domestic Individual | 3.98 | | E Fund Yuxiang Return Bond Fund | Unknown | 3.82 | | Hong Kong Securities Clearing Company Limited | Unknown | 3.74 | | Qiu Guisong | Domestic Individual | 3.65 | | Ming Tuzhang | Domestic Individual | 3.26 | | Hu Anbing | Domestic Individual | 2.88 | | SDIC UBS Optimized Enhanced Bond Fund | Unknown | 2.05 | | Yuan Jianhua | Domestic Individual | 2.04 | | ICBC Credit Suisse Strategic Transformation Theme Stock Fund | Unknown | 1.78 | | Wang Hui | Domestic Individual | 1.54 | Other Significant Matters Operational Highlights In Q1 2022, the company secured new business contracts totaling CNY 2.73 billion, marking a 35.50% year-over-year increase - In the first quarter of 2022, the company secured new business contracts totaling CNY 2.73 billion, representing a 35.50% increase compared to the same period last year12 Quarterly Financial Statements Consolidated Balance Sheet As of March 31, 2022, total assets were CNY 10.07 billion, a 5.85% decrease from year-end, while total liabilities decreased 10.84% to CNY 5.98 billion Key Items from Consolidated Balance Sheet | Item | March 31, 2022 (CNY) | December 31, 2021 (CNY) | | :--- | :--- | :--- | | Total Assets | 10,065,523,377.07 | 10,690,943,227.41 | | Total Liabilities | 5,977,549,977.43 | 6,703,901,871.26 | | Total Equity Attributable to Parent Company Shareholders | 3,981,083,171.29 | 3,878,208,225.67 | | Total Equity | 4,087,973,399.64 | 3,987,041,356.15 | Consolidated Income Statement In Q1 2022, total operating revenue reached CNY 917.01 million, up 14.09%, resulting in a net profit attributable to parent company shareholders of CNY 93.44 million, up 17.69% Key Items from Consolidated Income Statement | Item | Q1 2022 (CNY) | Q1 2021 (CNY) | | :--- | :--- | :--- | | Total Operating Revenue | 917,007,642.00 | 803,749,404.56 | | Total Operating Costs | 824,286,552.27 | 717,830,212.84 | | Operating Profit | 107,128,501.15 | 98,654,437.27 | | Total Profit | 107,243,798.86 | 98,649,490.52 | | Net Profit Attributable to Parent Company Shareholders | 93,435,319.02 | 79,389,202.91 | | Basic Earnings Per Share (CNY/share) | 0.14 | 0.12 | Consolidated Cash Flow Statement Net cash flow from operating activities was -CNY 296.02 million in Q1 2022, an improvement from -CNY 324.46 million in the prior year, with overall cash and equivalents decreasing by CNY 350.17 million Key Items from Consolidated Cash Flow Statement | Item | Q1 2022 (CNY) | Q1 2021 (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -296,019,165.49 | -324,456,563.72 | | Net Cash Flow from Investing Activities | -4,854,433.13 | -100,177,204.70 | | Net Cash Flow from Financing Activities | -49,290,541.52 | 91,684,519.05 | | Net Increase/Decrease in Cash and Cash Equivalents | -350,173,300.94 | -332,933,794.18 | | Cash and Cash Equivalents at Period End | 1,338,388,313.29 | 1,195,667,956.11 |
华设集团(603018) - 2022 Q1 - 季度财报